Abdera Therapeutics
Kelly Parker is a highly experienced Human Resources professional with a robust background in the biopharmaceutical sector. Currently serving as Senior Vice President of Human Resources at Abdera Therapeutics and Stealth Biotech, Kelly has held significant leadership roles, including Vice President & Chief People Officer and Executive Director & Chief People Officer at Avanir Pharmaceuticals. Prior experience includes Senior Director of Human Resources at Avanir and earlier roles in Human Resources at Allergan and as Area HR Director at Pulte Homes. Kelly Parker holds a Bachelor of Science degree in Psychology from San Diego State University.
This person is not in any offices
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.